-
32013D0504(02)
Commission Implementing Decision of 3 May 2013 on the financing of the 2013 work programme on IT tools in the field of food safety, animal health, animal welfare and plant health
OJ C 127, 4.5.2013, p. 3–13 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
32013D0196
2013/196/EU: Commission Implementing Decision of 24 April 2013 amending Implementing Decision 2012/715/EU establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union Text with EEA relevance
OJ L 113, 25.4.2013, p. 22–23 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52013PC0241
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT pursuant to Article 294(6) of the Treaty on the Functioning of the European Union concerning the position of the Council at first reading with a view to the adoption of a Regulation of the European Parliament and of the Council on food intended for infants and young children, food for special medical purposes and total diet replacement for weight control
/* COM/2013/0241 final - 2011/0156 (COD) */
-
52013PC0168
Amended proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems
/* COM/2013/0168 final - 2012/0035 (COD) */
-
32013D0129
2013/129/EU: Council Decision of 7 March 2013 on subjecting 4-methylamphetamine to control measures
OJ L 72, 15.3.2013, p. 11–12 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
32013R0198
Commission Implementing Regulation (EU) No 198/2013 of 7 March 2013 on the selection of a symbol for the purpose of identifying medicinal products for human use that are subject to additional monitoring Text with EEA relevance
OJ L 65, 8.3.2013, p. 17–18 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52013XX0308(01)
Guidelines of 7 March 2013 on Good Distribution Practice of Medicinal Products for Human Use
OJ C 68, 8.3.2013, p. 1–14 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52012AE2059
Opinion of the European Economic and Social Committee on the ‘Proposal for a Regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC’ COM(2012) 369 final — 2012/0192 (COD)
OJ C 44, 15.2.2013, p. 99–103 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52012IE1774
Opinion of the European Economic and Social Committee on ‘The European Year of Mental Health — Better work, better quality of life’ (own-initiative opinion)
OJ C 44, 15.2.2013, p. 36–43 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
32013D0051
2013/51/EU: Commission Implementing Decision of 23 January 2013 on the assessment of a third country’s regulatory framework applicable to active substances of medicinal products for human use and of the respective control and enforcement activities pursuant to Article 111b of Directive 2001/83/EC of the European Parliament and of the Council Text with EEA relevance
OJ L 21, 24.1.2013, p. 36–36 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
